Miguel Ángel Macías-Islas

MEXCTRIMS clinical practice guideline for the diagnosis and treatment of multiple sclerosis in Mexico. Part II

Gloria de L. Llamosa-García-Velázquez, Nayeli Alejandra Sánchez-Rosales, Francisco A. Rodríguez-Leal, Verónica Rivas‐Alonso et autres

International clinical guidelines aimed at improving the management of multiple sclerosis are difficult to apply to the Mexican health system. This guideline, developed by a group of expert neurologists, members of the Mexican Committee for the Treatment and Research in Multiple Sclerosis …

mx, cn (code pays fourni par la source)

MEXCTRIMS clinical practice guideline for the diagnosis and treatment of multiple sclerosis in Mexico. Part I

Gloria de L. Llamosa-García-Velázquez, Nayeli Alejandra Sánchez-Rosales, Francisco A. Rodríguez-Leal, Verónica Rivas‐Alonso et autres

International clinical guidelines aimed at improving the management of multiple sclerosis are difficult to apply to the Mexican health system. This guideline, developed by a group of expert neurologists, members of the Mexican Committee for the Treat-ment and Research in Multiple Sclerosis …

mx, cn (code pays fourni par la source)

Perri Spanish Auditory Verbal Learning and Memory Test: Normative Data for Elderly Adults from Mexico

Teresita J. Villaseñor-Cabrera, Miguel Ángel Macías-Islas, Karen A Sanchez-Jacuinde, Genoveva Rizo-Curiel et autres

Background: The Perri Auditory Verbal Learning Test (Perri-AVLT) is a cognitive tool designed to assess verbal learning and memory. Currently, demographically adjusted norms for the Perri-AVLT are not available for elderly Mexican adults. Objective: This study aimed to develop regression-based norms from …

mx, us (code pays fourni par la source)

Toward the Search for Clinical and Cognitive Variables that Affect Employment in LATAM: a Multicenter Study

Sandra Vanotti, Michael G. Jaworski, Oscar Daniel Ayala, María Sol Román et autres

ar, us, es, mx (code pays fourni par la source)

Guía de práctica clínica MEXCTRIMS para el diagnóstico y el tratamiento de la esclerosis múltiple en México. Parte I

Gloria de L. Llamosa-García-Velázquez, Nayeli Alejandra Sánchez-Rosales, Francisco A. Rodríguez-Leal, Verónica Rivas‐Alonso et autres

Las guías clínicas internacionales destinadas a mejorar el manejo de la esclerosis múltiple son difícilmente aplicables al sistema de salud mexicano. La presente guía, desarrollada por un grupo de neurólogos expertos, miembros del Comité Mexicano para el Tratamiento e Investigación en Esclerosis …

mx, cu (code pays fourni par la source)

Regression-Based Normative Data for the Perri Spanish Auditory Verbal Learning and Memory Test In Early-To-Midlife Mexican Adults

Teresita J. Villaseñor-Cabrera, Karen A Sanchez-Jacuinde, Miriam Jiménez-Maldonado, Alejandra Morlett Paredes et autres

Background The Perri Auditory Verbal Learning Test (Perri-AVLT) is a cognitive tool that is used to assess verbal learning and memory. To date, demographically adjusted norms for Perri-AVLT have not been identified for Mexican adults. Objectives This study aimed to 1) estimate …

mx, us, es (code pays fourni par la source)

A review of the validation of the Brief Cognitive Assessment for Multiple Sclerosis in Latin America

Miriam Jiménez-Maldonado, Edgar Ricardo Valdivia-Tangarife, Miguel Ángel Macías-Islas, Fernando Cortés-Enríquez et autres

Background: The present review aimed to identify published studies that reported the validation of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) in Latin America (LATAM). Methods: To compile a comprehensive list of available validation studies, we performed a systematic review of …

mx, us (code pays fourni par la source)

Association of the Val66Met Polymorphism of the BDNF Gene with the Depression in a Mexican Population with Multiple Sclerosis

Brenda Viridiana Rabago-Barajas, Miguel Ángel Macías-Islas, Ana Míriam Saldaña-Cruz, Jesús E. Yepez et autres

Multiple sclerosis (MS) is a chronic, autoimmune pathology that affects the nervous system. It is characterized by inflammatory lesions that cause axonal damage with neurodegeneration. The signs and symptoms present in this pathology include among others, psychiatric disorders. In MS, depression is …

mx (code pays fourni par la source)

Unusually young onset of spastic paraparesis in a carrier of both the A431E PSEN1 and A713T APP variants

John Matthew Ringman, Nasim Sheikh‐Bahaei, Enrique I. Velázquez Villareal, DAVID M. CRAIG et autres

BACKGROUND: The ways in which diverse genetic variants interact to affect the phenotype of AD is poorly understood. The relatively consistent phenotype associated with specific mutations causing autosomal dominant AD (ADAD) provides the opportunity to study how other genetic variants contribute to …

us, mx (code pays fourni par la source)

Syndecan-1 Levels in Females with Active Rheumatoid Arthritis

Norma Alejandra Rodriguez-Jimenez, Fabiola González-Ponce, Jorge Iván Gámez-Nava, Melissa Ramírez-Villafaña et autres

Background: The relationship between serum glycoprotein syndecan-1 and disease activity in rheumatoid arthritis (RA) is still unknown. This study aimed to evaluate whether serum syndecan-1 concentrations are associated with moderate/severe disease activity. Methods: Study Design: This was a cross-sectional study. Seventy-five adult …

mx (code pays fourni par la source)

Corrigendum to “Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in individuals with multiple sclerosis from Mexico” [Multiple Sclerosis and Related Disorders, Volume 83, March 2024, 105451]

Edgar Ricardo Valdivia-Tangarife, Alejandra Morlett Paredes, Teresita J. Villaseñor-Cabrera, Mario Alberto Mireles-Ramírez et autres

mx, us (code pays fourni par la source)

Risk Factors Associated with Adverse Events Leading to Methotrexate Withdrawal in Elderly Rheumatoid Arthritis Patients: A Retrospective Cohort Study

Felipe Alexis Avalos-Salgado, Laura González-López, Sergio Antonio González-Vázquez, Juan Manuel Ponce-Guarneros et autres

Background: Rheumatoid arthritis (RA) in elderly population represents a challenge for physicians in terms of therapeutic management. Methotrexate (MTX) is the first-line treatment among conventional synthetic-disease-modifying anti-rheumatic drugs (cs-DMARDs); however, it is often associated with adverse events (AEs). Therefore, the objective of …

mx (code pays fourni par la source)